Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin Test in China
Cancer Genetics (Nasdaq:CGIX) a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced that it has signed an exclusive distribution agreement with Genecast Biotechnology to market, distribute and sell the Tissue of OriginĀ (TOO) Test in China. As quoted in the press release: John A. Roberts, Chief Executive Officer ā¦
Cancer Genetics (Nasdaq:CGIX) a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced that it has signed an exclusive distribution agreement with Genecast Biotechnology to market, distribute and sell the Tissue of OriginĀ (TOO) Test in China.
As quoted in the press release:
John A. Roberts, Chief Executive Officer of Cancer Genetics, commented, āGenecast Biotechnology has an impressive, well-established menu of tumor DNA testing and gene-based tests, and is the optimal partner to bring our TOO test to the China market. TOO enables identification of tumors of unknown origin. We are excited to make this test available to cancer patients in China through Genecastās proven distribution capabilities in the space. This collaboration is in line with our business transformation strategy of driving sustainable, long-term growth and profitability by leveraging our unique assets.ā
Du Bo, Co-Founder and CEO of Genecast, said, āWe are excited to enter this collaboration with CGI. We believe that they offer a host of tests and services that can bring a paradigm change in the precision oncology space. More specifically, CGIās TOO test has the potential to improve lives of many cancer patients. The focus of this collaboration is to unlock the commercial opportunity of the TOO test in China while providing access to a broader cancer patient population and potentially improving clinical outcomes.ā
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1823.67 | -30.43 | |
Silver | 20.65 | -0.88 | |
Copper | 4.08 | -0.12 | |
Palladium | 1902.60 | -118.40 | |
Platinum | 945.50 | -46.00 | |
Oil | 105.47 | -0.24 | |
Heating Oil | 3.72 | -0.03 | |
Natural Gas | 7.70 | +0.06 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Featured stocks
Investing News Network websites or approved third-party tools use cookies. Please refer to theĀ cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Ā